•  
  •  
  •  
  •  

2026-08-05 00:05:23

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  Approval

IPO News

  • SEBI Clears IPO for EAAA India Alternatives Ltd, Edelweiss Subsidiary to Launch ₹15,000 Million OFS
  • VMS TMT Limited Gets SEBI Nod to Float an IPO
  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Icon Facilitators Announces BSE SME IPO Approval, Targets ₹22 Crore Fundraise
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO

Stock Report

  • Jeevan Scientific Technology Ltd receives CDSCO nod for increase in bed capacity
  • Dr. Reddy's Laboratories Receives U.S. FDA Approval for Rituximab Biosimilar
  • Lupin Announces the Approval of Diazepam Injection, USP in the United States
  • Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
  • NCLT Approves Resolution Plan for Wind World India by Authum Investment and Inox Neo Energies
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets, 1 mg and 2 mg
  • Kwality Pharmaceuticals Ltd receives CDSCO nod to Initiate Preclinical Pilot Batches of Pembroluzimab
  • Bondada Engineering Ltd receives approval from CEA
  • Glenmark Receives U.S. FDA Approval to Expand the Use of RYALTRIS® Nasal Spray for Children Aged 6 to Less Than 12 Years
  • Emcure to Expand the Use of Poviztra® for MASH Indication Following CDSCO Approval
  • Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg
  • NATCO receives Tentative Approval for Olaparib Tablets from the U.S. FDA
  • Anand Rathi Wealth Ltd's subsidiary receives in-principle approval from IFSCA
  • India Pesticides Ltd receives TEQ approval in EU for one Fungicide product
  • Mercury EV-Tech Secures GEDA Approval for E-Rickshaws in Gujarat; 11 Models Eligible for ₹48,000 Subsidy
  • Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa
  • IOL Chemicals and Pharmaceuticals Ltd receives approval from NMPA, China for Clopidogrel Bisulfate API
  • NTPC board approves investment in Lara Super Thermal Power Project
  • Cosmic CRF Subsidiary's Target Unit Secures RDSO Prototype Approval for Railway Springs
  • NATCO Pharma Ltd gets approval from its Board of Directors for increasing its stake in Adcock Ingram Holdings Proprietary Ltd to 49%
  • Lupin announces EMA Approval for NaMuscla® Expansion for Pediatric Indication with New Strengths
  • EPACK Durable Ltd receives Andhra Pradesh Government approval for ₹1,084.31 Crore combined investment under Electronics Manufacturing Policy 4.0
  • Approval of Merger scheme by Board of Directors of PFC and REC
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%

Industry News

  • ASK Asset & Wealth Management Group receives SEBI nod to launch its Mutual Fund business
  • Ashika Investment Managers Launches SmartAlpha Fund, a New Open-Ended Category III Data Strategy Fund
  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • Pre Construction Tips: Things to Check
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license
  • Insurance product approvals made easy - Steps towards ease of doing business

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025